English

GENOMIC SOLUTIONS INC

EDGAR

Quarterly report (10-Q) · filed 2002-08-14

12 filing records in this dataset, filed from 2000-08-14 to 2002-08-14. Explore the available filing history and original sources.

Inspect reported changes Compare with another company Historical disclosures Search filings Segments

Watchlist

Latest quarter

Revenue

6.04 million USD

2002-06-30 · USD

Exact inputs and evidence

Revenue: 6040000 USD Source

Operating margin

-34.27%

2002-06-30 · %

Exact inputs and evidence

Operating Income: -2070000 USD Source
Revenue: 6040000 USD Source

Operating cash flow

-1.95 million USD

2002-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -7554000 USD Source
Operating Cash Flow: -5607000 USD Source

Free cash flow

-1.97 million USD

2002-06-30 · USD

Exact inputs and evidence

Operating Cash Flow: -7554000 USD Source
Operating Cash Flow: -5607000 USD Source
Capital Expenditure: 149000 USD Source
Capital Expenditure: 123000 USD Source

Cash and cash equivalents: 5.27 million USD 2002-06-30 Source
Exact value

5266000 USD
Long-term debt including current maturities: Not available
Shares outstanding: Not available

Trailing twelve months

The four most recent complete quarters added together. This gives a full-year view that includes the latest quarterly results.

Revenue

20.7 million USD

2001-07-01 – 2002-06-30

Exact inputs and evidence

Revenue: 3629000 USD · 2001-07-01 – 2001-09-30 Source
Revenue: 16840000 USD · 2001-01-01 – 2001-12-31 Source
Revenue: 12471000 USD · 2001-01-01 – 2001-09-30 Source
Revenue: 6676000 USD · 2002-01-01 – 2002-03-31 Source
Revenue: 6040000 USD · 2002-04-01 – 2002-06-30 Source

Net income

-24.1 million USD

2001-07-01 – 2002-06-30

Exact inputs and evidence

Net income: -7853000 USD · 2001-07-01 – 2001-09-30 Source
Net income: -26100000 USD · 2001-01-01 – 2001-12-31 Source
Net income: -13771000 USD · 2001-01-01 – 2001-09-30 Source
Net income: -1582000 USD · 2002-01-01 – 2002-03-31 Source
Net income: -2381000 USD · 2002-04-01 – 2002-06-30 Source

Operating cash flow

-15.1 million USD

2001-07-01 – 2002-06-30

Exact inputs and evidence

Operating cash flow: -11069000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -6423000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -13960000 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -11069000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -5607000 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -7554000 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -5607000 USD · 2002-01-01 – 2002-03-31 Source

Capital expenditure

919 thousand USD

2001-07-01 – 2002-06-30

Exact inputs and evidence

Capital expenditure: 1826000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 1273000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 2043000 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 1826000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 123000 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 149000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 123000 USD · 2002-01-01 – 2002-03-31 Source

Free cash flow

-16 million USD

2001-07-01 – 2002-06-30

Exact inputs and evidence

Operating cash flow: -11069000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -6423000 USD · 2001-01-01 – 2001-06-30 Source
Operating cash flow: -13960000 USD · 2001-01-01 – 2001-12-31 Source
Operating cash flow: -11069000 USD · 2001-01-01 – 2001-09-30 Source
Operating cash flow: -5607000 USD · 2002-01-01 – 2002-03-31 Source
Operating cash flow: -7554000 USD · 2002-01-01 – 2002-06-30 Source
Operating cash flow: -5607000 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 1826000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 1273000 USD · 2001-01-01 – 2001-06-30 Source
Capital expenditure: 2043000 USD · 2001-01-01 – 2001-12-31 Source
Capital expenditure: 1826000 USD · 2001-01-01 – 2001-09-30 Source
Capital expenditure: 123000 USD · 2002-01-01 – 2002-03-31 Source
Capital expenditure: 149000 USD · 2002-01-01 – 2002-06-30 Source
Capital expenditure: 123000 USD · 2002-01-01 – 2002-03-31 Source

Includes later revisions to earlier periods. Annual charts exclude incomplete years.

Latest filing recorded: 2002-08-14.

Financial data available through: 2001-12-31.

Coverage by financial measure

Revenue: 4 of 11 periods available· newest 2001-12-31
Operating income: 4 of 11 periods available· newest 2001-12-31
Net income: 4 of 11 periods available· newest 2001-12-31
Operating cash flow: 4 of 11 periods available· newest 2001-12-31
Capital expenditure: 4 of 11 periods available· newest 2001-12-31
Total assets: 3 of 11 periods available· newest 2001-12-31
liabilities: No compatible figures in this window
Current assets: 3 of 11 periods available· newest 2001-12-31
Current liabilities: 3 of 11 periods available· newest 2001-12-31
Cash and cash equivalents: 4 of 11 periods available· newest 2001-12-31
long term debt: No compatible figures in this window
shares outstanding: No compatible figures in this window

Coverage describes values retained in this snapshot. Missing values are not zero; loading limits are reported separately.

What changed year over year

Latest complete year compared with the corresponding period one year earlier. These are measured changes; they do not establish their business causes.

Revenue
-11.7%

Prior period

USD 19.08 million

2000-01-01 – 2000-12-31
Current period

USD 16.84 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

16840000 − 19077000 = -2237000 USD

19077000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
16840000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Revenue · GENOMIC SOLUTIONS INC · 2001-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Year-over-year change in Revenue: -2237000 USD Concept: fundies:Revenue Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:Revenue: 16840000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#7217 Input fundies:Revenue: 19077000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#7217
The citation records this snapshot. The page link may show a newer release later.
Net income
−USD 17.2 million

Prior period

−USD 8.9 million

2000-01-01 – 2000-12-31
Current period

−USD 26.1 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-26100000 − -8904000 = -17196000 USD

-8904000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-26100000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Net income · GENOMIC SOLUTIONS INC · 2001-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Year-over-year change in Net income: -17196000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:NetIncome: -26100000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12164 Input fundies:NetIncome: -8904000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12164
The citation records this snapshot. The page link may show a newer release later.
Operating cash flow
−USD 2.82 million

Prior period

−USD 11.14 million

2000-01-01 – 2000-12-31
Current period

−USD 13.96 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

-13960000 − -11136000 = -2824000 USD

-11136000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
-13960000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Operating cash flow · GENOMIC SOLUTIONS INC · 2001-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Year-over-year change in Operating cash flow: -2824000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:OperatingCashFlow: -13960000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12552 Input fundies:OperatingCashFlow: -11136000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12552
The citation records this snapshot. The page link may show a newer release later.
Capital expenditure
+22.4%

Prior period

USD 1.67 million

2000-01-01 – 2000-12-31
Current period

USD 2.04 million

2001-01-01 – 2001-12-31

Exact inputs and evidence

2043000 − 1669000 = 374000 USD

1669000 USD · 2000-01-01 – 2000-12-31
Inspect prior input Prior source
2043000 USD · 2001-01-01 – 2001-12-31
Inspect current input Current source

Share or cite

Citation for Year-over-year change in Capital expenditure · GENOMIC SOLUTIONS INC · 2001-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Year-over-year change in Capital expenditure: 374000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384?view=overview&cadence=annual&surface=latest#period-changes-title Computed: Current period minus corresponding prior-year period Input fundies:CapitalExpenditure: 2043000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12609 Input fundies:CapitalExpenditure: 1669000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12609
The citation records this snapshot. The page link may show a newer release later.

Where revenue goes

How a period’s revenue divides into costs and what remains as profit. Items marked Derived are calculated by subtraction from reported figures.

2001 2001-01-01 – 2001-12-31

Revenue USD 16.84 million 100% of revenue
Cost of revenue USD 11.79 million 70% of revenue
Operating expenses USD 31.87 million 189% of revenue
Operating income −USD 26.82 million −159% of revenue
Tax, interest and other Derived −USD 721,000 −4.3% of revenue
Net income −USD 26.1 million −155% of revenue

Cash

Operating cash flow −USD 13.96 million −83% of revenue
Capital expenditure USD 2.04 million 12% of revenue
Free cash flow Derived −USD 16 million −95% of revenue

Share of revenue by period

Net income
Tax, interest and other
Operating costs

1998 Operating loss: operating costs were 242% of revenue.
1999 Operating loss: operating costs were 173% of revenue.
2000 Operating loss: operating costs were 144% of revenue.
2001 Operating loss: operating costs were 259% of revenue.

Values and sources

Revenue breakdown by annual reporting period
Period	Revenue	Operating costs	Operating income	Tax, interest and other	Net income	Free cash flow	Source
1998 1998-01-01 – 1998-12-31	5507000	13332000 Derived	-7825000	-39000 Derived	-7786000	-8605000 Derived	Source 1998-01-01 – 1998-12-31: 5507000 USD Inspect Revenue Open source 1998-01-01 – 1998-12-31: -7825000 USD Inspect Operating Income Open source 1998-01-01 – 1998-12-31: -7786000 USD Inspect Net Income Open source 1998-01-01 – 1998-12-31: -7274000 USD Inspect Operating Cash Flow Open source 1998-01-01 – 1998-12-31: 1331000 USD Inspect Capital Expenditure Open source
1999 1999-01-01 – 1999-12-31	12092000	20910000 Derived	-8818000	2324000 Derived	-11142000	-10973000 Derived	Source 1999-01-01 – 1999-12-31: 12092000 USD Inspect Revenue Open source 1999-01-01 – 1999-12-31: -8818000 USD Inspect Operating Income Open source 1999-01-01 – 1999-12-31: -11142000 USD Inspect Net Income Open source 1999-01-01 – 1999-12-31: -9524000 USD Inspect Operating Cash Flow Open source 1999-01-01 – 1999-12-31: 1449000 USD Inspect Capital Expenditure Open source
2000 2000-01-01 – 2000-12-31	19077000	27489000 Derived	-8412000	492000 Derived	-8904000	-12805000 Derived	Source 2000-01-01 – 2000-12-31: 19077000 USD Inspect Revenue Open source 2000-01-01 – 2000-12-31: -8412000 USD Inspect Operating Income Open source 2000-01-01 – 2000-12-31: -8904000 USD Inspect Net Income Open source 2000-01-01 – 2000-12-31: -11136000 USD Inspect Operating Cash Flow Open source 2000-01-01 – 2000-12-31: 1669000 USD Inspect Capital Expenditure Open source
2001 2001-01-01 – 2001-12-31	16840000	43661000 Derived	-26821000	-721000 Derived	-26100000	-16003000 Derived	Source 2001-01-01 – 2001-12-31: 16840000 USD Inspect Revenue Open source 2001-01-01 – 2001-12-31: -26821000 USD Inspect Operating Income Open source 2001-01-01 – 2001-12-31: -26100000 USD Inspect Net Income Open source 2001-01-01 – 2001-12-31: -13960000 USD Inspect Operating Cash Flow Open source 2001-01-01 – 2001-12-31: 2043000 USD Inspect Capital Expenditure Open source

Amounts are exact, in USD.

Growth

Sales over time and how quickly they are changing.

Revenue

Revenue reported for each complete financial period.

USD 16.8M 2001

Values and sources

Revenue values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Revenue	5507000	Revenue: 5507000 Open source
19991999-12-31	Revenue	12092000	Revenue: 12092000 Open source
20002000-12-31	Revenue	19077000	Revenue: 19077000 Open source
20012001-12-31	Revenue	16840000	Revenue: 16840000 Open source

Revenue growth

Change in revenue from the same financial period one year earlier.

-11.7% 2001

Values and sources

Revenue growth values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Year over year	No prior comparable period	Revenue: 5507000 Open source
19991999-12-31	Year over year	119.6%	Revenue: 12092000 Open source Revenue: 5507000 Open source
20002000-12-31	Year over year	57.8%	Revenue: 19077000 Open source Revenue: 12092000 Open source
20012001-12-31	Year over year	-11.7%	Revenue: 16840000 Open source Revenue: 19077000 Open source

Profit and cash

How much revenue becomes profit, and how much cash operations generate.

Profit margins

Operating income, net income and free cash flow as a share of revenue.

Operating margin -159.3% 2001

Net margin -155% 2001

Free cash flow margin -95% 2001

Operating margin
Net margin
Free cash flow margin

Values and sources

Profit margins values and source evidence
Period	Series	Value	Source evidence
19981998-12-31	Operating margin	-142.1%	Operating Income: -7825000 Open source Revenue: 5507000 Open source
19991999-12-31	Operating margin	-72.9%	Operating Income: -8818000 Open source Revenue: 12092000 Open source
20002000-12-31	Operating margin	-44.1%	Operating Income: -8412000 Open source Revenue: 19077000 Open source
20012001-12-31	Operating margin	-159.3%	Operating Income: -26821000 Open source Revenue: 16840000 Open source
19981998-12-31	Net margin	-141.4%	Net Income: -7786000 Open source Revenue: 5507000 Open source
19991999-12-31	Net margin	-92.1%	Net Income: -11142000 Open source Revenue: 12092000 Open source
20002000-12-31	Net margin	-46.7%	Net Income: -8904000 Open source Revenue: 19077000 Open source
20012001-12-31	Net margin	-155%	Net Income: -26100000 Open source Revenue: 16840000 Open source
19981998-12-31	Free cash flow margin	-156.3%	Revenue: 5507000 Open source Operating Cash Flow: -7274000 Open source Capital Expenditure: 1331000 Open source
19991999-12-31	Free cash flow margin	-90.7%	Revenue: 12092000 Open source Operating Cash Flow: -9524000 Open source Capital Expenditure: 1449000 Open source
20002000-12-31	Free cash flow margin	-67.1%	Revenue: 19077000 Open source Operating Cash Flow: -11136000 Open source Capital Expenditure: 1669000 Open source
20012001-12-31	Free cash flow margin	-95%	Revenue: 16840000 Open source Operating Cash Flow: -13960000 Open source Capital Expenditure: 2043000 Open source

Operating cash flow

Cash generated by the company’s normal business operations.

USD -14M 2001

Values and sources

Operating cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Operating cash flow	-7274000	Operating Cash Flow: -7274000 Open source
19991999-12-31	Operating cash flow	-9524000	Operating Cash Flow: -9524000 Open source
20002000-12-31	Operating cash flow	-11136000	Operating Cash Flow: -11136000 Open source
20012001-12-31	Operating cash flow	-13960000	Operating Cash Flow: -13960000 Open source

Free cash flow

Operating cash flow minus capital expenditure for the same period and unit.

USD -16M 2001

Values and sources

Free cash flow values and source evidence
Period	Series	Value(USD)	Source evidence
19981998-12-31	Free cash flow	-8605000	Operating Cash Flow: -7274000 Open source Capital Expenditure: 1331000 Open source
19991999-12-31	Free cash flow	-10973000	Operating Cash Flow: -9524000 Open source Capital Expenditure: 1449000 Open source
20002000-12-31	Free cash flow	-12805000	Operating Cash Flow: -11136000 Open source Capital Expenditure: 1669000 Open source
20012001-12-31	Free cash flow	-16003000	Operating Cash Flow: -13960000 Open source Capital Expenditure: 2043000 Open source

Balance sheet

Liabilities and short-term ability to meet obligations at each period end.

Liabilities to assets

Total liabilities as a share of total assets.

Not enough comparable data to show this history.

Values and sources

Liabilities to assets values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Liabilities / assets	Not reported	No source recorded
1999-12-31	Liabilities / assets	Not reported	Total Assets: 13858000 Open source
2000-12-31	Liabilities / assets	Not reported	Total Assets: 65224000 Open source
2001-12-31	Liabilities / assets	Not reported	Total Assets: 47924000 Open source

Current assets to current liabilities

Current assets divided by current liabilities.

2.18× 2001

Values and sources

Current assets to current liabilities values and source evidence
Period	Series	Value	Source evidence
1998-12-31	Current assets / current liabilities	Not reported	No source recorded
19991999-12-31	Current assets / current liabilities	1.29×	Current Assets: 9070000 Open source Current Liabilities: 7020000 Open source
20002000-12-31	Current assets / current liabilities	5.06×	Current Assets: 54795000 Open source Current Liabilities: 10825000 Open source
20012001-12-31	Current assets / current liabilities	2.18×	Current Assets: 29133000 Open source Current Liabilities: 13367000 Open source

Cash generation

Compare reported profit with operating cash and capital spending. Free cash flow is calculated as operating cash flow minus capital expenditure when both exact, consolidated amounts match the same period and unit.

Cash generation by annual reporting period
Period	Net income	Operating cash flow	Capital expenditure	Free cash flow
1998 1998-01-01 – 1998-12-31	−USD 7.79 million Exact value Exact value: -7786000 USD 1998-01-01 – 1998-12-31: -7786000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMIC SOLUTIONS INC · 1998-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Net Income: -7786000 USD Concept: fundies:NetIncome Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3ANetIncome&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:NetIncome: -7786000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-01-001959.txt#11277 The citation records this snapshot. The page link may show a newer release later.	−USD 7.27 million Exact value Exact value: -7274000 USD 1998-01-01 – 1998-12-31: -7274000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC SOLUTIONS INC · 1998-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Operating Cash Flow: -7274000 USD Concept: fundies:OperatingCashFlow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3AOperatingCashFlow&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -7274000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-01-001959.txt#11708 The citation records this snapshot. The page link may show a newer release later.	USD 1.33 million Exact value Exact value: 1331000 USD 1998-01-01 – 1998-12-31: 1331000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC SOLUTIONS INC · 1998-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Capital Expenditure: 1331000 USD Concept: fundies:CapitalExpenditure Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3ACapitalExpenditure&period=1998-12-31&surface=latest&period_type=duration&start=1998-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1331000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-01-001959.txt#11769 The citation records this snapshot. The page link may show a newer release later.	−USD 8.61 million Calculation and evidence -7274000 − 1331000 USD Exact free cash flow: -8605000 USD 1998-01-01 – 1998-12-31: -7274000 USD · Inspect Operating Cash Flow · Source 1998-01-01 – 1998-12-31: 1331000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC SOLUTIONS INC · 1998-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Free cash flow: -8605000 USD Concept: free-cash-flow Period: 1998-01-01 to 1998-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -7274000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-01-001959.txt#11708 Input fundies:CapitalExpenditure: 1331000 USD (1998-01-01 to 1998-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-01-001959.txt#11769 The citation records this snapshot. The page link may show a newer release later.
1999 1999-01-01 – 1999-12-31	−USD 11.14 million Exact value Exact value: -11142000 USD 1999-01-01 – 1999-12-31: -11142000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMIC SOLUTIONS INC · 1999-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Net Income: -11142000 USD Concept: fundies:NetIncome Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3ANetIncome&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:NetIncome: -11142000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12164 The citation records this snapshot. The page link may show a newer release later.	−USD 9.52 million Exact value Exact value: -9524000 USD 1999-01-01 – 1999-12-31: -9524000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC SOLUTIONS INC · 1999-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Operating Cash Flow: -9524000 USD Concept: fundies:OperatingCashFlow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3AOperatingCashFlow&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -9524000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12552 The citation records this snapshot. The page link may show a newer release later.	USD 1.45 million Exact value Exact value: 1449000 USD 1999-01-01 – 1999-12-31: 1449000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC SOLUTIONS INC · 1999-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Capital Expenditure: 1449000 USD Concept: fundies:CapitalExpenditure Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3ACapitalExpenditure&period=1999-12-31&surface=latest&period_type=duration&start=1999-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1449000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12609 The citation records this snapshot. The page link may show a newer release later.	−USD 10.97 million Calculation and evidence -9524000 − 1449000 USD Exact free cash flow: -10973000 USD 1999-01-01 – 1999-12-31: -9524000 USD · Inspect Operating Cash Flow · Source 1999-01-01 – 1999-12-31: 1449000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC SOLUTIONS INC · 1999-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Free cash flow: -10973000 USD Concept: free-cash-flow Period: 1999-01-01 to 1999-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -9524000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12552 Input fundies:CapitalExpenditure: 1449000 USD (1999-01-01 to 1999-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12609 The citation records this snapshot. The page link may show a newer release later.
2000 2000-01-01 – 2000-12-31	−USD 8.9 million Exact value Exact value: -8904000 USD 2000-01-01 – 2000-12-31: -8904000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMIC SOLUTIONS INC · 2000-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Net Income: -8904000 USD Concept: fundies:NetIncome Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3ANetIncome&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:NetIncome: -8904000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12164 The citation records this snapshot. The page link may show a newer release later.	−USD 11.14 million Exact value Exact value: -11136000 USD 2000-01-01 – 2000-12-31: -11136000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC SOLUTIONS INC · 2000-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Operating Cash Flow: -11136000 USD Concept: fundies:OperatingCashFlow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3AOperatingCashFlow&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -11136000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12552 The citation records this snapshot. The page link may show a newer release later.	USD 1.67 million Exact value Exact value: 1669000 USD 2000-01-01 – 2000-12-31: 1669000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC SOLUTIONS INC · 2000-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Capital Expenditure: 1669000 USD Concept: fundies:CapitalExpenditure Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3ACapitalExpenditure&period=2000-12-31&surface=latest&period_type=duration&start=2000-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 1669000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12609 The citation records this snapshot. The page link may show a newer release later.	−USD 12.81 million Calculation and evidence -11136000 − 1669000 USD Exact free cash flow: -12805000 USD 2000-01-01 – 2000-12-31: -11136000 USD · Inspect Operating Cash Flow · Source 2000-01-01 – 2000-12-31: 1669000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC SOLUTIONS INC · 2000-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Free cash flow: -12805000 USD Concept: free-cash-flow Period: 2000-01-01 to 2000-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -11136000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12552 Input fundies:CapitalExpenditure: 1669000 USD (2000-01-01 to 2000-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12609 The citation records this snapshot. The page link may show a newer release later.
2001 2001-01-01 – 2001-12-31	−USD 26.1 million Exact value Exact value: -26100000 USD 2001-01-01 – 2001-12-31: -26100000 USD Inspect Net Income Open source Share or cite Citation for Net Income · GENOMIC SOLUTIONS INC · 2001-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Net Income: -26100000 USD Concept: fundies:NetIncome Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3ANetIncome&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:NetIncome: -26100000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12164 The citation records this snapshot. The page link may show a newer release later.	−USD 13.96 million Exact value Exact value: -13960000 USD 2001-01-01 – 2001-12-31: -13960000 USD Inspect Operating Cash Flow Open source Share or cite Citation for Operating Cash Flow · GENOMIC SOLUTIONS INC · 2001-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Operating Cash Flow: -13960000 USD Concept: fundies:OperatingCashFlow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3AOperatingCashFlow&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:OperatingCashFlow: -13960000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12552 The citation records this snapshot. The page link may show a newer release later.	USD 2.04 million Exact value Exact value: 2043000 USD 2001-01-01 – 2001-12-31: 2043000 USD Inspect Capital Expenditure Open source Share or cite Citation for Capital Expenditure · GENOMIC SOLUTIONS INC · 2001-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Capital Expenditure: 2043000 USD Concept: fundies:CapitalExpenditure Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384/explain?concept=fundies%3ACapitalExpenditure&period=2001-12-31&surface=latest&period_type=duration&start=2001-01-01&unit=USD&dimensions= Input fundies:CapitalExpenditure: 2043000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12609 The citation records this snapshot. The page link may show a newer release later.	−USD 16 million Calculation and evidence -13960000 − 2043000 USD Exact free cash flow: -16003000 USD 2001-01-01 – 2001-12-31: -13960000 USD · Inspect Operating Cash Flow · Source 2001-01-01 – 2001-12-31: 2043000 USD · Inspect Capital Expenditure · Source Share or cite Citation for Free cash flow · GENOMIC SOLUTIONS INC · 2001-12-31 GENOMIC SOLUTIONS INC (edgar:1053384) Free cash flow: -16003000 USD Concept: free-cash-flow Period: 2001-01-01 to 2001-12-31 Values: Latest reported Published: 2026-11-06T02:32:03Z Snapshot: b9cf72b9d3c659f36f16331902abfa6beab22c02b1e63be0947d3b6efac71f3b Dimensions: Consolidated View: https://fundies.io/companies/edgar/1053384?view=overview&cadence=annual&surface=latest#cash-generation-title Computed: Operating cash flow minus capital expenditure Input fundies:OperatingCashFlow: -13960000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12552 Input fundies:CapitalExpenditure: 2043000 USD (2001-01-01 to 2001-12-31) Dimensions: Consolidated Source: https://www.sec.gov/Archives/edgar/data/1053384/0000950124-02-001177.txt#12609 The citation records this snapshot. The page link may show a newer release later.

Capital expenditure uses the canonical mapped positive-spending convention. A missing, ambiguous, incompatible, or negative-sign input is left blank. Values use the latest reported version.

Dataset coverage and company identifiers

Coverage reflects filings processed into this Fundies dataset; it does not imply every source filing is loaded.

12 filings · 0 latest values · 0 originally reported values

Dataset published 2026-11-06. Source filing dates and reporting periods are shown separately.

Identifiers: 0001053384, 1053384, edgar:1053384

GENOMIC SOLUTIONS INC

Latest quarter

Revenue

Operating margin

Operating cash flow

Free cash flow

Trailing twelve months

Revenue

Net income

Operating cash flow

Capital expenditure

Free cash flow

Company performance

What changed year over year

Revenue

Net income

Operating cash flow

Capital expenditure

Where revenue goes

2001 2001-01-01 – 2001-12-31

Cash

Share of revenue by period

Growth

Profit and cash

Balance sheet

Cash generation